Clinical trials
Phase 1 Diabetes Mellitus, Type 2 trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 2 |
| Sciwind Biosciences APAC CO Pty. Ltd. | 2 |
| Biolexis Therapeutics | 1 |
| Biomed Industries, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Carmot Australia First Pty Ltd | 1 |
| Eilean Therapeutics | 1 |
| GlaxoSmithKline | 1 |
| HighTide Therapeutics (Hong Kong) Limited | 1 |
| QL Biopharmaceutical Australia Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 13 |
| Obesity | 5 |
| Diabetes Mellitus | 3 |
| Dyslipidemias | 2 |
| Overweight | 2 |
| Hyperglycemia | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Metabolic Diseases | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.